Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens
Phase of Trial: Phase I
Latest Information Update: 05 Apr 2017
At a glance
- Drugs PEPIDH1M (Primary) ; Temozolomide
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- Acronyms PERFORMANCE
- 08 Dec 2016 Status changed from not yet recruiting to recruiting.
- 29 Nov 2016 Planned initiation date changed from 1 Oct 2016 to 1 Dec 2016.
- 18 Aug 2016 New trial record